<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(12)</volume><submitter>Bakkers MJG</submitter><pubmed_abstract>Respiratory syncytial virus (RSV) is a major cause of severe respiratory disease in infants and older people. Current RSV subunit vaccines are based on a fusion protein that is stabilized in the prefusion conformation and linked to a heterologous foldon trimerization domain to obtain a prefusion F (preF) trimer. Here we show that current RSV vaccines induce undesirable anti-foldon antibodies in non-human primates, mice and humans. To overcome this, we designed a foldon-free RSV preF trimer by elucidating the structural basis of trimerization-induced preF destabilization through molecular dynamics simulations and by introducing amino acid substitutions that negate hotspots of charge repulsion. The highly stable prefusion conformation was validated using antigenic and cryo-electron microscop</pubmed_abstract><journal>Nature microbiology</journal><pagination>3254-3267</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11602707</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses.</pubmed_title><pmcid>PMC11602707</pmcid><pubmed_authors>van der Fits L</pubmed_authors><pubmed_authors>Le L</pubmed_authors><pubmed_authors>Vaneman J</pubmed_authors><pubmed_authors>Thoma A</pubmed_authors><pubmed_authors>Zahn R</pubmed_authors><pubmed_authors>van Overveld D</pubmed_authors><pubmed_authors>Tettero L</pubmed_authors><pubmed_authors>Koornneef A</pubmed_authors><pubmed_authors>Bakkers MJG</pubmed_authors><pubmed_authors>Cox F</pubmed_authors><pubmed_authors>Juraszek J</pubmed_authors><pubmed_authors>van den Hoogen W</pubmed_authors><pubmed_authors>Langedijk JPM</pubmed_authors><pubmed_authors>Voorzaat R</pubmed_authors><pubmed_authors>Yu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses.</name><description>Respiratory syncytial virus (RSV) is a major cause of severe respiratory disease in infants and older people. Current RSV subunit vaccines are based on a fusion protein that is stabilized in the prefusion conformation and linked to a heterologous foldon trimerization domain to obtain a prefusion F (preF) trimer. Here we show that current RSV vaccines induce undesirable anti-foldon antibodies in non-human primates, mice and humans. To overcome this, we designed a foldon-free RSV preF trimer by elucidating the structural basis of trimerization-induced preF destabilization through molecular dynamics simulations and by introducing amino acid substitutions that negate hotspots of charge repulsion. The highly stable prefusion conformation was validated using antigenic and cryo-electron microscop</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-06-02T06:24:44.577Z</modification><creation>2025-04-04T09:59:09.838Z</creation></dates><accession>S-EPMC11602707</accession><cross_references><pubmed>39567664</pubmed><doi>10.1038/s41564-024-01860-1</doi></cross_references></HashMap>